AI can transform pharmaceutical marketing by scaling personalized content development and delivery and optimizing processes. But it must be deployed responsibly, with clear guardrails to ensure compliance.
We’re thrilled to be as a Diamond partner for Fierce Pharma Engage 2025 on April 29 - May 1, 2025, at the Town and Country Resort in San Diego, CA.
Join us in Savannah as Ahmed Elsayyad, President and co-founder of Ostro, will join industry thought leaders for an insightful panel on better HCP engagement.
As of October 1, 2024, pharmaceutical companies promoting prescription medicines in the UK must adhere to the revised standards outlined in the new Association of the British Pharmaceutical Industry (ABPI) 2024 Code of Conduct.
In the global fight against HIV, a twice-yearly injection could represent a seismic shift in prevention efforts.
The Healthcare Technology Report has recognized Ostro as one of the Top 100 Healthcare Technology Companies of 2024.
Is time spent on your website a sign of engagement or frustration? For pharma brands, recognizing the difference between productive and non-productive actions is crucial to driving meaningful engagement.
At Ostro, we don’t make new medicines, but we like to say that our talent is making medicine make sense.
The pharma sector faces a critical challenge: bridging the widening digital divide. To keep pace with rapid technological advancements, companies need to break down silos and integrate their digital initiatives, ensuring a seamless and effective approach to innovation.